| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/30/2011 | CN101993390A (d1)beta-(3,4-dihydroxyphenyl)-alpha-hydroxypropionyl hydrazide and preparation method, drug composition and application thereof |
| 03/30/2011 | CN101993389A D(+)beta-(3,4-dihydroxyphenyl)-alpha-hydroxypropionyl hydrazide and preparation method, drug composition and application thereof |
| 03/30/2011 | CN101991859A Beta-cyclodextrin inclusion compound of huperzine A, and preparation method and preparation thereof |
| 03/30/2011 | CN101991816A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
| 03/30/2011 | CN101991814A 一种具有祛风化痰和活血通络功能的制剂及制备方法 Formulation and preparation method of expelling phlegm and have Huoxuetongluo function |
| 03/30/2011 | CN101991798A Medicament for treating apoplexy |
| 03/30/2011 | CN101991787A Traditional Chinese medicine heal-care tea with effects of moistening lung and lowering blood pressure |
| 03/30/2011 | CN101991780A Chinese material medical preparation for treating apoplexy |
| 03/30/2011 | CN101991743A Traditional Chinese medicine for treating diabetic heart disease |
| 03/30/2011 | CN101991729A Medicinal liquor for relaxing muscles and tendons |
| 03/30/2011 | CN101991712A Radix gentianae healthcare tea capable of reducing blood pressure |
| 03/30/2011 | CN101991705A Guayule antihypertension tea |
| 03/30/2011 | CN101991695A Traditional Chinese medicine pill for treating hemorrhoids and preparation method thereof |
| 03/30/2011 | CN101991691A Preparation method of hemorrhoids ointment |
| 03/30/2011 | CN101991674A Composition of safflower oil and hawthorn extracts and application thereof |
| 03/30/2011 | CN101991671A Traditional Chinese medicine for treating diabetic eye disease |
| 03/30/2011 | CN101991669A Quality control method of medicine |
| 03/30/2011 | CN101991668A Application of traditional Chinese medicinal composition in preparing medicament for improving filamentous actin expression |
| 03/30/2011 | CN101991665A Composition for treating myocardial diseases, femoral head necrosis and tumor and preparation process thereof |
| 03/30/2011 | CN101991663A Liquid total paeony glycoside composite and preparation method thereof |
| 03/30/2011 | CN101991648A Traditional Chinese medicine for treating diabetic coronary heart disease |
| 03/30/2011 | CN101991647A Traditional Chinese medicine for treating diabetic coronary heart diseases |
| 03/30/2011 | CN101991645A Preparation for treating coronary heart disease and preparation method thereof |
| 03/30/2011 | CN101991644A Composition of safflower oil and salvia extracts and application thereof |
| 03/30/2011 | CN101991628A Process for preparing non-toxic extractive from asarum heterotropoides |
| 03/30/2011 | CN101991620A Medicament prepared from okra extractive and application thereof |
| 03/30/2011 | CN101991616A Traditional Chinese medicine composite for coronary heart disease and angina pectoris and preparation method thereof |
| 03/30/2011 | CN101991614A Compound fermented cordyceps sinensis powder (paecilomyces hepiali Cs-4 bacterial powder) combined medicine and preparation thereof |
| 03/30/2011 | CN101991612A Preparation method of haematococcus pluvialis extracts |
| 03/30/2011 | CN101991609A Efficient three-in-one royal jelly soft capsule |
| 03/30/2011 | CN101991606A Preparation method of solid water-soluble lead-removed propolis |
| 03/30/2011 | CN101991604A Forest frog oil capsules and preparation method |
| 03/30/2011 | CN101991602A New method for preparing compound cerebroprotin hydrolysate |
| 03/30/2011 | CN101991597A Applications of oral pharmaceutical composition to preparation of medicament for preventing or treating kidney diseases |
| 03/30/2011 | CN101991596A Application of oral medicine composition in preparation of medicines for preventing or treating coronary heart disease |
| 03/30/2011 | CN101991593A Application of quercetin in medicament preparation |
| 03/30/2011 | CN101991590A Stilbene glucoside medical composite and preparation method thereof |
| 03/30/2011 | CN101991589A Glycerol fructose injection and preparation method thereof |
| 03/30/2011 | CN101991573A Corynoxeine and application of isomer thereof in preparing medicines |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101991547A Preparation method of sodium ferulate freeze-dried powder injection |
| 03/30/2011 | CN101991535A Docosahexaenoic acid (DHA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 03/30/2011 | CN101991534A EPA (eicoeapentaenoieaeid) ester fat emulsion intravenous injection and preparation method thereof |
| 03/30/2011 | CN101991533A Puerarin liposome microsphere injection and preparation method thereof |
| 03/30/2011 | CN101991530A Vinpocetine containing high-capacity sodium chloride injection and preparation method thereof |
| 03/30/2011 | CN101991127A Powdery mixture containing phytosterol and oryzanol and preparation method thereof |
| 03/30/2011 | CN101991108A Preparation method of fruit and vegetable juice for treating hypertension and arteriosclerosis |
| 03/30/2011 | CN101991099A Ginseng can |
| 03/30/2011 | CN101991058A Method for preparing nut and lotus seed porridge |
| 03/30/2011 | CN101990971A Method for preparing Indian buead persimmon leaf tea |
| 03/30/2011 | CN101990967A Sweet orange fruit tea and processing technology thereof |
| 03/30/2011 | CN101683363B Composition preparation of ginkgo biloba extract and dipyridamole and preparation method thereof |
| 03/30/2011 | CN101623378B Chinese medicament for treating high blood pressure |
| 03/30/2011 | CN101623276B Compound radix salviae miltiorrhizae essence capsule for treating apoplexy and preparation technique thereof |
| 03/30/2011 | CN101612349B Medicine for treating coronary heart disease |
| 03/30/2011 | CN101569614B Puerarin lagging cover slowly-releasing dripping pill and preparing method thereof |
| 03/30/2011 | CN101416950B Preparation method of cmellia sponin controlled release tablets |
| 03/30/2011 | CN101401942B Azelnidipine composition |
| 03/30/2011 | CN101396495B Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 03/30/2011 | CN101229264B Chinese traditional medicine prescription and preparation of active ingredient thereof |
| 03/30/2011 | CN101190180B Metoprolol sustained release medicinal compositions and preparation method thereof |
| 03/30/2011 | CN101185643B Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 03/30/2011 | CN101007790B Oxamic acid derivative, and its preparation method and medicinal uses |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | US7915231 Antisense modulation of C-reactive protein expression |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7914537 Devices and methods for the restoration of a spinal disc |
| 03/29/2011 | CA2494892C Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2472114C 2-o-(.beta.-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositons comprising it |
| 03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2447040C Assays, methods and means |
| 03/29/2011 | CA2446327C A polypeptide and dna thereof useful as a neovascular marker |
| 03/29/2011 | CA2420562C Creatine ester pronutrient compounds and formulations |
| 03/29/2011 | CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 03/24/2011 | WO2011035110A2 Treatment for oxidative stress and/or hypertension |
| 03/24/2011 | WO2011034583A2 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | WO2011034580A2 Small peptide modulators of potassium channel trafficking |
| 03/24/2011 | WO2011034513A1 The granules with improved solubility and stability |
| 03/24/2011 | WO2011034464A1 Injectable dosage form for the treatment of an acute ischaemic insult and cranial trauma, manufacturing method and use |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011034051A1 Novel cyclic squaramide derivatives |
| 03/24/2011 | WO2011033717A1 Goya koji composition |
| 03/24/2011 | WO2011033229A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033225A2 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011032233A1 Novel omega conotoxin peptides |
| 03/24/2011 | WO2010127642A9 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof |
| 03/24/2011 | WO2010127096A3 Novel therapeutic treatments using centhaquin |